Body composition parameters were associated with response to abiraterone acetate and prognosis in patients with metastatic castration-resistant prostate cancer.

Zhi-Bin KeQi YouYu-Ting XueJiang-Bo SunJia-Yin ChenWen-Qi LiuYong WeiQing-Shui ZhengXiao-Dong LiXue-Yi Xue Ning Xu

Published in: Cancer medicine (2023)

High SMI and low PPFA/PA could predict biochemical response to AA treatment and preferable prognosis in mCRPC patients with prior chemohormonal therapy at hormone-sensitive stage.

Keyphrases

body composition
resistance training
bone mineral density
stem cells
postmenopausal women
mesenchymal stem cells
replacement therapy
bone marrow